BioArctic AB's (publ) partner Eisai today presented results from the real-world Lecanemab in Early Alzheimer's Disease (LEADER) Study showing that nearly 83% of patients with early Alzheimer's disease ...
Zacks.com on MSN
Centene Stock Soars 66% YTD: Should Investors Chase the Rally?
Centene Corporation CNC, one of the largest managed healthcare providers in the United States, has staged an impressive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results